Picard Medical Profit Margin

The latest profit margin for PMI is -444.3% as of June 2026. That compares with -629.48% in the prior-year period — up 29.4% year over year. That is below the sector sector average of 22.52%. Investors often review this figure alongside Picard Medical's historical trend and sector peers before judging valuation or financial health.

Over the past year, PMI's profit margin moved from -629.48% to -444.3% — a 29.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Picard Medical's valuation or profitability profile.

Against its sector companies, PMI currently prints -444.3% for profit margin, while the sector average sits near 22.52%. That is roughly 2072.9% below the sector mean. Large gaps often invite a closer look at Picard Medical's growth, margins, and balance sheet.

Profit Margin shows how effectively Picard Medical converts resources into returns. At -444.3%, PMI may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -629.48% in the prior-year period — up 29.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting PMI's profit margin (-444.3%), review year-over-year change from -629.48%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.